Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The HALO study: A phase I-II of the oral HSP90 inhibitor Debio0932 in combination with SOC in first- and second-line therapy of advanced NSCLC

Lookup NU author(s): Professor Ruth PlummerORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Jaime JC, Paz-Ares L, Provencio M, Bennouna J, Ponce-Aix S, Plummer R, Delord JP, Isambert N, Trigo JM, Belli R, Brienza S, Zanna C, Purcea D, Calvo V, Alonso M, Senellart H, Hiret S, Marti AM, Felip E

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 2014 Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2014

Pages: TPS2632

Print publication date: 20/05/2014

Acceptance date: 01/01/1900

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology

URL: https://doi.org/10.1200/jco.2014.32.15_suppl.tps2632

DOI: 10.1200/jco.2014.32.15_suppl.tps2632

Series Title: Journal of Clinical Oncology

Share